Stocksigma LogoStocksigma Logo

Epigral Board to Consider Q2 and H1 Financial Results on 2nd Nov'26

Epigral Limited has scheduled its Board of Directors meeting for 2nd Nov'26 to consider, approve, and take on record the standalone and consolidated

Epigral Board to Consider Q2 and H1 Financial Results on 2nd Nov'26

Epigral Ltd 路 Intimation 路 02 Nov 2026, 5:30 am

Epigral Board to Consider Q2 and H1 Financial Results on 2nd Nov'26 Epigral Limited has scheduled its Board of Directors meeting for 2nd Nov'26 to consider, approve, and take on record the standalone and consolidated unaudited financial results for the second quarter and half year ended 30th Sep'26. The board will also review the Statutory Auditors' Limited Review Report for the period, in compliance with Regulation 29 of SEBI LODR Regulations, 2015.

Original exchange filing (PDF)

More announcements from Epigral Ltd

All Epigral Ltd announcements